PT - JOURNAL ARTICLE AU - Machi, Dustin AU - Bhattacharya, Parantapa AU - Hoops, Stefan AU - Chen, Jiangzhuo AU - Mortveit, Henning AU - Venkatramanan, Srinivasan AU - Lewis, Bryan AU - Wilson, Mandy AU - Fadikar, Arindam AU - Maiden, Tom AU - Barrett, Christopher L. AU - Marathe, Madhav V. TI - Scalable Epidemiological Workflows to Support COVID-19 Planning and Response AID - 10.1101/2021.02.23.21252325 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.23.21252325 4099 - http://medrxiv.org/content/early/2021/02/26/2021.02.23.21252325.short 4100 - http://medrxiv.org/content/early/2021/02/26/2021.02.23.21252325.full AB - The COVID-19 global outbreak represents the most significant epidemic event since the 1918 influenza pandemic. Simulations have played a crucial role in supporting COVID-19 planning and response efforts. Developing scalable workflows to provide policymakers quick responses to important questions pertaining to logistics, resource allocation, epidemic forecasts and intervention analysis remains a challenging computational problem. In this work, we present scalable high performance computing-enabled workflows for COVID-19 pandemic planning and response. The scalability of our methodology allows us to run fine-grained simulations daily, and to generate county-level forecasts and other counter-factual analysis for each of the 50 states (and DC), 3140 counties across the USA. Our workflows use a hybrid cloud/cluster system utilizing a combination of local and remote cluster computing facilities, and using over 20,000 CPU cores running for 6–9 hours every day to meet this objective. Our state (Virginia), state hospital network, our university, the DOD and the CDC use our models to guide their COVID-19 planning and response efforts. We began executing these pipelines March 25, 2020, and have delivered and briefed weekly updates to these stakeholders for over 30 weeks without interruption.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially supported by National Institutes of Health (NIH) Grant 1R01GM109718, NSF BIG DATA Grant IIS-1633028, NSF Grant No.: OAC-1916805, NSF Expeditions in Computing Grant CCF-1918656, CCF-1917819, NSF RAPID CNS-2028004, NSF RAPID OAC-2027541, US Centers for Disease Control and Prevention 75D30119C05935, University of Virginia Strategic Investment Fund award number SIF160, Google Grant, and Defense Threat Reduction Agency (DTRA) under Contract No. HDTRA1-19-D-0007. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funding agencies. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data can be shared upon request